Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye

Clinical trial NCT00799552 · COMPLETED

Trial details

NCT number: NCT00799552
Sponsor: Resolvyx Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Syndrome

Start date: 2008-11-01
Primary completion: 2009-05-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.